These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9650536)

  • 21. Protecting the residual renal function: how do ACE inhibitors and calcium antagonists compare?
    Maschio G
    Nephron; 1994; 67(3):257-62. PubMed ID: 7936013
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacologic treatment of hypertension in the Department of Veterans Affairs during 1995 and 1996.
    Siegel D; Lopez J; Meier J
    Am J Hypertens; 1998 Nov; 11(11 Pt 1):1271-8. PubMed ID: 9832168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy.
    Opie LH; Schall R
    J Am Coll Cardiol; 2002 Jan; 39(2):315-22. PubMed ID: 11788225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Rifkin W
    JAMA; 2003 Apr 23-30; 289(16):2068; author reply 2069-70. PubMed ID: 12709459
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiotensin converting enzyme inhibitors, calcium channel blockers, and their combination in the treatment of glomerular disease.
    Ritz E; Orth SR; Strzelczyk P
    J Hypertens Suppl; 1997 Mar; 15(2):S21-6. PubMed ID: 9218194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misperceptions about beta-blockers and diuretics: a national survey of primary care physicians.
    Ubel PA; Jepson C; Asch DA
    J Gen Intern Med; 2003 Dec; 18(12):977-83. PubMed ID: 14687255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STOP-Hypertension-2 and best practice for the future.
    Hannson L
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i2-4:discussion i50. PubMed ID: 10956309
    [No Abstract]   [Full Text] [Related]  

  • 29. Calcium channel blockers in hypertension: reappraisal after new trials and major meta-analyses.
    Opie LH
    Am J Hypertens; 2001 Oct; 14(10):1074-81. PubMed ID: 11710789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hypertension from volume to vasoconstriction: The ACE up your sleeve.
    Stanley JC; Samson RH
    Semin Vasc Surg; 2002 Dec; 15(4):225-36. PubMed ID: 12478497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined therapy as first-line treatment for arterial hypertension].
    Glezer MG
    Ter Arkh; 2005; 77(10):93-6. PubMed ID: 16320697
    [No Abstract]   [Full Text] [Related]  

  • 32. Resistant Hypertension: Which Agent?
    Prosser HCG; Azzam O; Schlaich MP
    Heart Lung Circ; 2018 Aug; 27(8):911-916. PubMed ID: 29526418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
    Bakris GL; Toto RD; McCullough PA; Rocha R; Purkayastha D; Davis P;
    Kidney Int; 2008 Jun; 73(11):1303-9. PubMed ID: 18354383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of new coronary events in older persons with prior myocardial infarction and systemic hypertension treated with beta blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium antagonists, and alpha blockers.
    Aronow WS; Ahn C
    Am J Cardiol; 2002 May; 89(10):1207-9. PubMed ID: 12008178
    [No Abstract]   [Full Text] [Related]  

  • 35. [Beta blockers and diuretics: therapeutic drugs of first choice in diabetes mellitus and hypertension].
    Sawicki PT
    Wien Klin Wochenschr; 1995; 107(21):629-39. PubMed ID: 8578749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of hypertension. What is the role of beta blockers?
    Gifford RW
    Postgrad Med; 1988 Feb; Spec No():46-9. PubMed ID: 2894661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of calcium channel blockers for hypertension questioned.
    Health News; 2005 Apr; 11(4):5. PubMed ID: 15818763
    [No Abstract]   [Full Text] [Related]  

  • 39. [The ALLHAT study (antihypertensive and lipid-lowering treatment to prevent heart attack trial): primary antihypertensive agents - diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors].
    Scholze J; Unger T
    Internist (Berl); 2003 Sep; 44(9):1193-5. PubMed ID: 14566471
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of antihypertensive drugs in the Italian hospitals. GIFA group. Gruppo Italiano di Farmacoepidemiologia nell'Anziano.
    Crucitti A; Cecchi E; Gensini GF; Simone I; Conti A; Gialloni S; Pedone C; Pahor M; Mugelli A
    Pharmacol Res; 2000 Feb; 41(2):249-53. PubMed ID: 10623493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.